Article citationsMore>>

Judson, I., Verweij, J., Gelderblom, H., Hartmann, J.T., Schöffski, P., Blay, J., et al. (2014) Doxorubicin Alone versus Intensified Doxorubicin Plus Ifosfamide for First-Line Treatment of Advanced or Metastatic Soft-Tissue Sarcoma: A Randomised Controlled Phase 3 Trial. The Lancet Oncology, 15, 415-423.
https://doi.org/10.1016/s1470-2045(14)70063-4

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top